Internal Medicine, Hematology & Oncology · Daphne, AL
NPI
1316092109
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
29653 Anchor Cross Blvd
Daphne, AL, 36526
Phone (251) 625-6896
Groups this clinician bills Medicare through
Medicare paid, 2024
$3.3M
229,283 services
Medicare patients, 2024
840
Average age 76
Drug cost, 2024
$9.8M
4,360 prescriptions
Company payments, 2025
$3,175
From 43 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Joseph R Jones was code J1439 (injection, ferric carboxymaltose, 1 mg), 22,500 times for 18 patients. In total Joseph R Jones billed 229,283 services in 162 codes, and Medicare paid $3.3M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-10-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 22,500 | 18 | $0.88 | $20K |
| J1453 Injection, fosaprepitant, 1 mg | Office | 17,550 | 33 | $0.11 | $1,903 |
| Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 13,260 | 15 | $0.26 | $3,512 |
| J9271 Injection, pembrolizumab, 1 mg | Office | 11,600 | 21 | $44.41 | $515K |
| J0897 Injection, denosumab, 1 mg | Office | 9,780 | 67 | $20.37 | $199K |
| J9267 Injection, paclitaxel, 1 mg | Office | 3,810 | 13 | $0.08 | $298 |
| Q5106 Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | Office | 3,161 | 17 | $5.78 | $18K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 2,044 | 62 | $0.09 | $180 |
| J9030 Bcg live intravesical instillation, 1 mg | Office | 1,750 | 13 | $2.28 | $3,987 |
| 36415 Venipuncture Blood Collection | Office | 1,605 | 486 | $8.65 | $14K |
| 85025 Blood Count | Office | 1,528 | 440 | $7.61 | $12K |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 1,350 | 39 | $0.68 | $925 |
| 80053 Clinical Chemistry | Office | 1,103 | 415 | $10.34 | $11K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 808 | 429 | $11.89 | $9,605 |
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 784 | 20 | $0.06 | $50.94 |
By year: 2022 $4.0M for 185,869 services; 2023 $3.5M for 177,862 services; 2024 $3.3M for 229,283 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,605 | 486 | $8.65 | $14K |
| 85025 Blood Count | 1,528 | 440 | $7.61 | $12K |
| 80053 Clinical Chemistry | 1,103 | 415 | $10.34 | $11K |
| 88185 Surgical Pathology Examination | 391 | 16 | $16.21 | $6,337 |
| 82784 Immunoassay | 273 | 27 | $9.11 | $2,488 |
| 83521 Immunoassay | 210 | 35 | $16.93 | $3,554 |
| 84443 Clinical Chemistry | 185 | 40 | $16.46 | $3,045 |
| 84439 Clinical Chemistry | 185 | 40 | $8.84 | $1,635 |
| 82728 Clinical Chemistry | 134 | 83 | $13.28 | $1,780 |
| 83540 Clinical Chemistry | 130 | 81 | $6.30 | $819 |
Medicare prescription drug claims, 2024
In 2024, the drug Joseph R Jones prescribed most often to Medicare patients was Letrozole, with 193 prescriptions and refills. In total Joseph R Jones wrote 4,360 Medicare prescriptions that cost $9.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Letrozole Generic | 193 | 395 | 51 | $3,820 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 174 | 174 | 59 | $5,240 |
| Ondansetron Hcl Generic | 156 | 157 | 91 | $2,437 |
| Exemestane Generic | 149 | 357 | 37 | $32K |
| Lenalidomide Generic | 142 | 142 | 20 | $1.7M |
| Hydroxyurea Generic | 113 | 191 | 20 | $2,502 |
| Prednisone Generic | 113 | 114 | 30 | $654 |
| Levothyroxine Sodium Generic | 106 | 169 | 26 | $654 |
| Prochlorperazine Maleate Generic | 103 | 103 | 63 | $1,585 |
| Eliquis Apixaban | 102 | 116 | 25 | $57K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 100 | 100 | 30 | $4,358 |
| Acyclovir Generic | 91 | 121 | 18 | $852 |
| Furosemide Generic | 78 | 89 | 16 | $293 |
| Dexamethasone Generic | 76 | 86 | 32 | $2,074 |
| Abiraterone Acetate Generic | 75 | 75 | Under 11 | $61K |
Brand drugs: 899 claims; generic drugs: 3,438 claims; opioid claims: 445.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Joseph R Jones $3,175 ($3,175 in general payments such as food, travel and fees) from 43 companies. The largest payer was Merck Sharp & Dohme LLC with $263.
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC MRK | 12 | $263 |
| Novartis Pharmaceuticals Corporation NVS | 12 | $263 |
| AstraZeneca Pharmaceuticals LP AZN | 13 | $240 |
| Janssen Biotech, Inc. JNJ | 13 | $237 |
| Exelixis Inc. EXEL | 4 | $200 |
| Celgene Corporation BMY | 6 | $158 |
| Eisai Inc. 4523.T | 5 | $116 |
| E.R. Squibb & Sons, L.L.C. BMY | 6 | $116 |
| Genentech USA, Inc. ROG.SW | 6 | $110 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 4 | $86.16 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.